Press Releases

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede for Alpha-Mannosidosis

Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced that the U.S. FDA has approved Lamzede® (velmanase alfa-tycv) for the treatment of non-central nervous system manifestations of alpha-mannosidosis (AM)...

Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, announced a strategic research and development collaboration to discover and develop...

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of  messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement to establish a...

IFPW Launches Environmental, Social, and Corporate Governance Framework To Serve as a Resource for the Pharmaceutical Industry

The International Federation of Pharmaceutical Wholesalers (IFPW), in partnership with member companies including global healthcare company AmerisourceBergen and IQVIA, a leading provider of advanced analytics and technology solutions, launched an ESG framework and toolkit to serve as a resource...

Mespack and Famartec Deliver Integrated Solution to Pharmaceutical Industry

Mespack and Famartec are pleased to announce their collaboration regarding the development of a high-quality integrated solution for the pharmaceutical sector; the solution will integrate primary and secondary packaging. The growing demand from pharmaceutical customers for a complete solution to address their production...

Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the completion of a $2.2 million expansion to its clinical supply facility in Singapore, which has seen the site’s footprint increase to...

West Pharma Expands Corning Collaboration and Launches First Product

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announces the expansion of its landmark collaboration with Corning Incorporated , that now includes the exclusive distribution rights for Corning Valor® Glass vials and the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read